Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trial

Title
Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trial
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 76, Issue 14 Supplement, Pages CT020-CT020
Publisher
American Association for Cancer Research (AACR)
Online
2016-07-27
DOI
10.1158/1538-7445.am2016-ct020

Ask authors/readers for more resources

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started